Delix Therapeutics

Panora, Iowa, United States

https://www.delixtherapeutics.com

Company profile

Delix Therapeutics company profile

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel neuroplasticity-promoting therapeutics—to better treat mental health disorders at scale. The company was founded in 2019 and is headquartered in Boston, Massachusetts.

Business identity

Website: https://www.delixtherapeutics.com
Operating status: Active
Company type: For Profit
Employee range: 11-50 employees
Revenue range: $0-$1M
Founded: 2019-01-01, Year

Headquarters

Headquarters: Panora, Iowa, United States
Country code: US
Continent: North America

Capital profile

Funding and company signals

Funding stage: Early Stage Venture
Funding rounds: 8
Total equity funding: $103M
Last funding: Series B / $25M / 2025-09-10
Last equity funding: Series B / $25M
Investors: 25
Lead investors: 7
Founders: 2
Articles: 67

Categories and groups

Biotechnology Health Care Life Science Neuroscience Biotechnology Health Care Science and Engineering

Founders and investors

Founders

David E. OlsonNick Haft

Lead investors

Artis VenturesComerica - Technology & Life SciencesNational Institute on Drug Abuse (NIDA)OMX VenturesRA Capital ManagementUC Davis Health VenturesU.S. Department of Defense

Investors

Artis VenturesGaingelsPresight CapitalPsyMed VenturesRA Capital Management